Study for Improving Maternal, Pregnancy and Child Outcomes

CompletedOBSERVATIONAL
Enrollment

13,000

Participants

Timeline

Start Date

November 9, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Pre-Eclampsia
Interventions
DIAGNOSTIC_TEST

history

combining these 4 interventions will great an algorithm predicting preeclampsia

Trial Locations (9)

Unknown

Eskilstuna hospital, Eskilstuna

Södra Älvsborgs sjukhus, Borås

Norra Älvsborgs sjukhus, Trollhättan

County Council Dalarna, Falun

Gothenburg University, Sahlgrenska academy, dept of obstetrics and gynecology, Gothenburg

Lund University Hospital, dept of obstetrics and gynecology, Lund

Örebro University Hospital, Örebro

Karolinska Institute, Stockholm

Uppsala University Hopsital, department of women's and children's health, Uppsala

All Listed Sponsors
collaborator

Thermo Fisher Scientific, Inc

INDUSTRY

collaborator

Perkin Elmer Inc.

INDUSTRY

collaborator

Roche Pharma AG

INDUSTRY

lead

Uppsala University

OTHER

NCT03831490 - Study for Improving Maternal, Pregnancy and Child Outcomes | Biotech Hunter | Biotech Hunter